Printer Friendly

I-FLOW EXPECTS TO REPORT APPROXIMATELY $2.0 MILLION IN REVENUES FOR THE 1992 YEAR, A 700 PERCENT INCREASE OVER THE PRIOR YEAR

 IRVINE, Calif., Feb. 3 /PRNewswire/ -- I-FLOW Corp. (NASDAQ: IFLO), manufacturer and seller of innovative ambulatory infusion devices, today announced that it expects to report total revenues of approximately $2.0 million (unaudited) for the year ended Dec. 31, 1992, an increase of more than 700 percent over the $239,000 reported for the year ended Dec. 31, 1991. For the quarter ended Dec. 31, 1992, the company expects to report total revenues greater than $800,000 (unaudited). I-FLOW is an early stage company and is still reporting net losses on a quarterly basis, although such net losses are expected to narrow in 1993. The reported net loss for the year ended Dec. 31, 1992 is expected to be in the range of $4.0 million to $4.3 million (unaudited), which includes certain non- recurring charges to earnings in the fourth quarter of approximately $500,000.
 Donald M. Earhart, president and chief executive officer, commented, "Reaching almost $2 million in total revenues for the year is a tremendous achievement for I-FLOW. This strong performance proves again the growing market acceptance of our cost effective ambulatory infusion systems -- the VIVUS 4000 and the SideKick. With these two systems I-FLOW is responding to increasing demands to reduce the health care costs associated with the IV delivery of medicines at alternate care sites." In conclusion, Earhart added, "The level of revenue achieved in 1992 gives us a strong base on which to build for continued growth in 1993."
 I-FLOW Corp. designs, develops, manufactures and markets technically advanced ambulatory infusion systems uniquely well suited to the alternate care environment. Reliable, efficient and easy to use, I-FLOW products offer users substantial opportunities to expand their therapy base, improve quality of care and increase productivity. These advantages translate into improved revenues and profits for health care providers while reducing costs and improving the quality of life for patients.
 -0- 2/3/93
 /CONTACT: Jim Dal Porto, VP-finance and administration of I-FLOW, 714-553-0888/
 (IFLO)


CO: I-FLOW Corp. ST: California IN: MTC SU: ERP

LS-KJ -- LA008 -- 2237 02/03/93 09:00 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1993
Words:345
Previous Article:MERCURY AIR GROUP REPORTS SECOND QUARTER AND SIX-MONTH RESULTS
Next Article:DIGITAL BIOMETRICS ANNOUNCES PROPOSED PUBLIC STOCK OFFERING
Topics:


Related Articles
NERCO REPORTS THIRD-QUARTER RESULTS; UPDATE ON MINERALS SUBSIDIARY
SCRIPPS RELEASES YEAR-END RESULTS
THE PROMUS COMPANIES INCORPORATED REPORTS YEAR END AND FOURTH QUARTER RECORDS
PULITZER PUBLISHING COMPANY REPORTS FOURTH-QUARTER AND 1992 RESULTS
PENN CENTRAL ANNOUNCES 1992 EARNINGS
SANTA FE PACIFIC PIPELINE PARTNERS ANNOUNCES EARNINGS
ADELPHIA COMMUNICATIONS ANNOUNCES FISCAL YEAR END RESULTS
I-FLOW TO REPORT $1.6 MILLION IN REVENUES FOR THE SECOND QUARTER OF 1993, A 434 PERCENT INCREASE OVER THE SAME PERIOD IN THE PRIOR YEAR
I-FLOW TO REPORT $1.6 MILLION IN REVENUES FOR THE THIRD QUARTER OF 1993, A 169 PERCENT INCREASE OVER THE SAME PERIOD IN THE PRIOR YEAR
I-FLOW EXPECTS TO REPORT APPROXIMATELY $5.7 MILLION IN REVENUES FOR THE 1993 YEAR, A 185 PERCENT INCREASE OVER THE PRIOR YEAR

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters